—Combines Three Leading Human Biomimetic Organoid Platform Technologies for Neurological Drug Discovery— —AxoSim Gains microBrain™ Intellectual Property from StemoniX, Along With Expert Scientific Team and Advanced R&D and Manufacturing Facility in Minnesota— —AxoSim to Begin Offering microBrain Products and Services Under Interim Distribution Agreement Effective Immediately— NEW ORLEANS and CHERRY HILL, N.J. — AxoSim, Inc., a leader in the […]

HexaCard allows the identification of clonality and provides a genetic ID card for each clone or batch, ensuring the integrity and accuracy of the entire production pipeline. BAGNEUX, France — Genomic Vision (FR0011799907 – GV, – the “Company”), a Euronext-listed biotechnology company that develops products and services for the highly accurate characterization of DNA sequences, is pleased […]

CSM is using the SOPHiA DDM™ Platform to expand its next-generation sequencing (NGS) offerings  BOSTON and ROLLE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Gruppo Centro Servizi Medici (CSM), one of the largest centralized laboratories in Italy, is live on SOPHiA GENETICS technology. CSM has […]

NETRI introduces the world’s first commercially available MEA-capable organs-on-chip line, NeuroFluidics™ MEA, composed of three compartmentalized microfluidic devices powered by Axion Biosystems’ integrated MEA technology and compatible with Maestro Pro and Maestro Edge systems. Lyon, France – NETRI today announces the commercial launch of its groundbreaking NeuroFluidics™ MEA line, developed in collaboration with U.S-based biotechnology leader Axion […]

Oxford Nanopore Technologies plc, the company delivering a new generation of nanopore-based molecular sensing technology, is pleased to announce that Kate Priestman will be joining the Group as Non-Executive Director with effect from 13 July 2023. Oxford Nanopore’s molecular sensing platform is increasingly a technology of choice in life science-based industries and applications, from biopharma and […]

Edwin Hauw brings over 20 years of marketing and product management experience to Element as the company expands to provide genomics tools for researchers around the world SAN DIEGO, CA – Element Biosciences, Inc., developer of the Element AVITI™ System, an innovative DNA sequencing platform that is disrupting the genomics industry, today announced the appointment of Edwin Hauw […]

A High-throughput Protein Biomarker Discovery Platform with Proven Specificity at Any Scale UPPSALA, Sweden — Olink Holding AB (publ) (Nasdaq: OLK) today announced the introduction of Olink® Explore HT, a transformational solution for high-throughput proteomics delivering unmatched specificity, scalability, and workflow simplicity. Olink Explore HT represents a significant advancement in next generation proteomics, allowing scientists to accurately […]

SINGAPORE – Next Level Genomics Pte Ltd, a Singapore-based provider of advanced genomics solutions to researchers and clinician scientists, has installed the first PacBio Revio next-generation sequencing instrument in Singapore. The Revio is the new high-throughput sequencing system from Pacific Biosciences (PacBio), the pioneers of long-read sequencing technology from the United States. The Revio combines […]

Merck announces the expansion of its facility in Lenexa, Kansas, USA adding 9,100 sq m² of lab space. Lenexa, Kansas, USA facility becomes company’s largest dry powder cell culture media facility and Center of Excellence in North America Boosts capabilities with additional 9,100 sq m2 of manufacturing and redesigned lab space Investment to bring 60 […]

2023 marks five years of industry-leading DRAGEN software offered by Illumina SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of the latest version of DRAGEN™ software for analysis of next-generation sequencing data. DRAGEN 4.2 expands award-winning accuracy combined with its renowned flexibility and scalability to […]